Welcome to LookChem.com Sign In|Join Free
  • or
2-(3,4-Dichlorophenyl)-N-[1-(S)-(3-methoxymethyloxyphenyl)-2-(3-(S)-tetrahydropyranyloxypyrrolidin-1-yl)ethyl]-N-tetrahydropyranyloxy-acetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

183540-25-2

Post Buying Request

183540-25-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

183540-25-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 183540-25-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,5,4 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 183540-25:
(8*1)+(7*8)+(6*3)+(5*5)+(4*4)+(3*0)+(2*2)+(1*5)=132
132 % 10 = 2
So 183540-25-2 is a valid CAS Registry Number.

183540-25-2Downstream Products

183540-25-2Relevant academic research and scientific papers

Pyrrolidinyl hydroxamic acid compounds and their production process

-

, (2008/06/13)

A compound of formula (I) STR1 and its pharmaceutically acceptable salt, wherein A is hydrogen or OY, wherein Y is a hydroxy protecting group; Ar is phenyl optionally substituted with one or more substituents selected from halo, hydroxy, C1 -C4 alkyl, C1 -C4 alkoxy, CF3, C1 -C4 alkoxy-C1 -C4 alkyloxy and carboxy-C1 -C4 alkyloxy; X is phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiophenyl, 1-tetralone-6-yl,C1 -C4 alkylenedioxy, pyridyl, furyl and thienyl these groups optionally being substituted with up to three substituents selected from halo, C1 -C4 alkyl, C1 -C4 alkoxy, hydroxy, NO2, CF3 and SO2 CH3 ; and R is hydrogen, C1 -C4 alkyl or a hydroxy protecting group. These compounds and pharmaceutical compositions containing them are useful as analgesic, anti-inflammatory, diuretic, anesthetic or neuroprotective agents, or an agent for stroke or treatment of functional bowel diseases such as abdominal pain, for the treatment of a mammalian subject, especially a human subject. Further, the present invention provides processes for producing the hydroxamic compounds of formula (I) and their intermediate compounds of the formula. STR2

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 183540-25-2